Subcutaneous infliximab may be ‘more effective’ after drug holiday
NASHVILLE, Tenn. — Antidrug antibodies did not appear to negatively affect outcomes in patients with inflammatory bowel disease after initiation of subcutaneous infliximab following a “drug holiday,” according to a presenter. Results of a post-hoc analysis presented at ACG Annual Scientific Meeting also showed serum in
